Codes / ICD10CM / T57.3X4D

T57.3X4D Toxic effect of hydrogen cyanide, undetermined, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of hydrogen cyanide, undetermined, subsequent encounter

Summary

This condition describes the adverse health effects resulting from exposure to hydrogen cyanide, where the intent of exposure is undetermined, and the encounter is classified as subsequent. Hydrogen cyanide is a highly toxic compound that inhibits cellular respiration, leading to systemic toxicity. The severity of effects depends on the dose, route of exposure, and duration. Subsequent encounters indicate ongoing management or follow-up after the initial toxic event.

Causes

Toxic effects occur when the body is exposed to hydrogen cyanide through inhalation, ingestion, or dermal contact. Sources may include industrial chemicals, combustion byproducts, or environmental contaminants. The undetermined intent suggests the exposure circumstances are unclear, and the subsequent encounter reflects continued care following the initial event.

Risk Factors

  • Occupational or environmental exposure to cyanide sources without clear intent.
  • Unclear circumstances of exposure (e.g., accidental, intentional, or unknown).
  • Lack of immediate context to determine exposure intent during initial assessment.
  • Ongoing medical management after the acute toxic event.

Symptoms

  • Persistent or recurring symptoms related to cyanide toxicity, such as headache, dizziness, or respiratory distress.
  • Signs of cellular hypoxia, including confusion, shortness of breath, or cyanosis.
  • Gastrointestinal symptoms like nausea, vomiting, or abdominal pain.
  • Neurological effects such as seizures, coma, or altered mental status.

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory findings. Blood or tissue tests may detect cyanide levels, though results can be time-sensitive. Clinical correlation with symptoms of cellular hypoxia and exclusion of other causes is essential. The undetermined intent and subsequent encounter status are documented based on the clinical context and follow-up timing.

Treatment Options

Treatment focuses on supportive care and specific antidotes (e.g., hydroxocobalamin, sodium thiosulfate) to counteract cyanide toxicity. Management may include oxygen therapy, airway support, and monitoring for organ dysfunction. Subsequent encounters involve reassessment, symptom management, and addressing any residual effects from the initial exposure.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial exposure and response to treatment. Subsequent encounters allow for monitoring of recovery, resolution of symptoms, or management of chronic effects. Follow-up may include repeat testing, functional assessments, or referrals to specialists based on residual complications.

Complications

  • Persistent neurological deficits or organ damage from severe exposure.
  • Recurrent symptoms if exposure sources remain unresolved.
  • Psychological impacts from the uncertainty of exposure intent.
  • Long-term monitoring requirements for delayed toxic effects.

Lifestyle & Prevention

  • Avoidance of known cyanide sources (e.g., industrial chemicals, contaminated environments).
  • Use of personal protective equipment in high-risk settings.
  • Education on recognizing and responding to potential cyanide exposure.
  • Prompt medical evaluation for unexplained symptoms in at-risk environments.

When to Seek Professional Help

Seek immediate medical attention for symptoms of cyanide toxicity, such as sudden respiratory distress, confusion, or loss of consciousness. Subsequent encounters require follow-up if symptoms persist, worsen, or new complications arise. Ongoing care is necessary for monitoring recovery and addressing unresolved effects.

Tips for Medical Coders

Document the undetermined intent of exposure and subsequent encounter status clearly. Code T57.3X4D is appropriate when the exposure intent is unknown and the encounter occurs during the recovery or follow-up phase. Ensure clinical documentation supports the classification, including details of the initial event and ongoing management.

Book a walkthrough

T57.3X4D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.